Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Concordance Between the Methods Used in INCa Platforms and the Cobas® 4800 BRAF V600 Mutation Test for Detection of BRAF V600 Mutations in Melanoma in Real Life Setting

NCT01744860 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01744860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01744860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Concordance Between the Methods Used in INCa Platforms and the Cobas® 4800 BRAF V600 Mutation Test for Detection of BRAF V600 Mutations in Melanoma in Real Life Setting
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
April 30, 2013
Enrollment
420 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma